|
|
||||||||
Articles |
Institute of Neurophysiology, University of Cologne, Robert Koch Strasse 39, D-50931 Cologne, Germany.
OBJECTIVE: Adrenaline inhibits insulin secretion through activation of alpha(2)-adrenoceptors (ARs). These receptors are linked to pertussis toxin-sensitive G proteins. Agonist binding leads to inhibition of adenylyl cyclase, inhibition of Ca(2+) channels and activation of K(+) channels. Recently, three distinct subtypes of alpha(2)-AR were described, alpha(2A)-AR, alpha(2B)-AR and alpha(2C)-AR. At present, it is unknown which of these alpha(2)-AR subtype(s) may regulate insulin secretion. We used mice deficient in alpha(2)-ARs to analyze the coupling and role of individual alpha(2)-AR subtypes in insulin-secreting beta cells. METHODS: The inhibitory effect of adrenaline on insulin secretion was measured in freshly isolated and cultured wild type (wt) and alpha(2)-AR knockout (KO) mouse islets in order to examine the receptor subtypes which mediate adrenaline-induced inhibition of insulin secretion. Adenylyl cyclase activity was measured in isolated cultured islets. Membrane potential was measured using the amphotericin B permeabilized patch clamp method in isolated and cultured single islet cells. RESULTS: In wt, alpha(2A)- and alpha(2C)-AR KO mouse islets, adrenaline, 1 microM/L, inhibited secretion by 83, 80 and 100% respectively. In contrast, in alpha(2A/2C)-AR double KO mouse islets, adrenaline had no effect on stimulated secretion indicating that both alpha(2A)-AR and alpha(2C)-AR, but not alpha(2B)-AR, are functionally expressed in mouse islets. Surprisingly, glucose (16.7 mM/L)-induced secretion in the presence of 1 microM/L forskolin was greatly impaired in alpha(2A)-AR KO islets. However, when cAMP levels were increased further by the combination of forskolin (5 microM/L) and 3-isobutyl-1-methylxanthine (100 microM/L), secretion was stimulated 2.7-fold (8.5-fold in wt islets). Adrenaline lowered the concentration of cAMP in wt and alpha(2C)-AR KO mouse islets by 74%. Adrenaline also hyperpolarized wt and alpha(2C)-AR KO beta cells. In contrast, adrenaline did not inhibit adenylyl cyclase in islets of alpha(2A)-AR KO mice, nor did it hyperpolarize alpha(2A)-AR KO beta cells. CONCLUSION: Adrenaline inhibits insulin release through alpha(2A)- and alpha(2C)-ARs via distinct intracellular signaling pathways.
This article has been cited by other articles:
![]() |
M. Kobayashi, H. Ohnishi, H. Okazawa, Y. Murata, Y. Hayashi, H. Kobayashi, T. Kitamura, and T. Matozaki Expression of Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 in Pancreatic {beta}-Cells and Its Role in Promotion of Insulin Secretion and Protection against Diabetes Endocrinology, November 1, 2008; 149(11): 5662 - 5669. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-J. Dong, Y. Guo, P. Agey, L. Wheeler, and W. A. Hare {alpha}2 Adrenergic Modulation of NMDA Receptor Function as a Major Mechanism of RGC Protection in Experimental Glaucoma and Retinal Excitotoxicity Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4515 - 4522. [Abstract] [Full Text] [PDF] |
||||
![]() |
Weizhen Wu, Jin Shang, Yue Feng, C. M. Thompson, S. Horwitz, J. R. Thompson, E. D. Macintyre, N. A. Thornberry, K. Chapman, Y.-P. Zhou, et al. Identification of Glucose-Dependent Insulin Secretion Targets in Pancreatic {beta} Cells by Combining Defined-Mechanism Compound Library Screening and siRNA Gene Silencing J Biomol Screen, February 1, 2008; 13(2): 128 - 134. [Abstract] [PDF] |
||||
![]() |
S. A. Bavadekar, G. Ma, S. M. Mustafa, B. M. Moore, D. D. Miller, and D. R. Feller Tethered Yohimbine Analogs as Selective Human {alpha}2C-Adrenergic Receptor Ligands J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 739 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, D. Friedman, S. Hill, R. Caprioli, W. Nicholson, A. C Powers, L. Hunter, and L. E Limbird Proteomic exploration of pancreatic islets in mice null for the {alpha}2A adrenergic receptor J. Mol. Endocrinol., August 1, 2005; 35(1): 73 - 88. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |